Huntington’s disease poses a threat to the brain—the core governing system of sensation, intellectual ability, nerve-related ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

PTC Therapeutics halts Utreloxastat development after ALS trial disappoints. Analysts highlight promising pipeline, including ...

The genetic mutation that causes Huntington's disease (HD)—a devastating brain disease that disrupts mobility and diminishes ...

The Phase II DIMENSION study of Sage's dalzanemdor failed to meet its primary and secondary endpoints for treating Huntington ...

After previously failing studies in Parkinson’s and Alzheimer’s, dalzanemdor’s latest stumble in Huntington’s disease has ...

Huntington's disease (HD) is a neurological disorder caused by a genetic mutation passed down through families. The disease destroys cells in different parts of the brain, causing symptoms that get ...

Sage Therapeutics (SAGE) stock falls as Huntington's Disease candidate dalzanemdor fails in Phase 2 trial. Read more here.

The Huntington's disease (HD) mutation eventually causes a fatal brain disease in adulthood, but a new study finds that early in life, children with the HD mutation have bigger brains and higher IQ ...

Huntington's Disease is one of the most devastating diseases out there and many people have never heard of it. Actor WIll ...

Scientists at La Trobe University have created a world-first method to investigate "disordered" proteins in living cells, in ...